C145H146F6N30O5 — CID 167646573
9-[[4-[1-(azetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-7-methyl-2-(2-propan-2-ylphenyl)purin-8-one;7-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;7-[[4-[3-(1-methylpiperidin-4-yl)pyrazol-1-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;7-[[4-[3-(1-methylpyrrolidin-3-yl)pyrazol-1-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-9-[[4-(3H-pyrrol-2-yl)phenyl]methyl]-7H-purin-8-one (PubChem CID 167646573) has the molecular formula C145H146F6N30O5 and a molecular weight of 2502.96 g/mol. Its IUPAC name is 9-[[4-[1-(azetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-7-methyl-2-(2-propan-2-ylphenyl)purin-8-one;7-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;7-[[4-[3-(1-methylpiperidin-4-yl)pyrazol-1-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;7-[[4-[3-(1-methylpyrrolidin-3-yl)pyrazol-1-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-9-[[4-(3H-pyrrol-2-yl)phenyl]methyl]-7H-purin-8-one.
| Compound Name | 9-[[4-[1-(azetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-7-methyl-2-(2-propan-2-ylphenyl)purin-8-one;7-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;7-[[4-[3-(1-methylpiperidin-4-yl)pyrazol-1-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;7-[[4-[3-(1-methylpyrrolidin-3-yl)pyrazol-1-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-9-[[4-(3H-pyrrol-2-yl)phenyl]methyl]-7H-purin-8-one |
|---|---|
| PubChem CID | 167646573 |
| Molecular Formula | C145H146F6N30O5 |
| Molecular Weight | 2502.96 g/mol |
| Exact Mass | 2501.20 |
| IUPAC Name | 9-[[4-[1-(azetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-7-methyl-2-(2-propan-2-ylphenyl)purin-8-one;7-[[4-[1-(1-methylazetidin-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;7-[[4-[3-(1-methylpiperidin-4-yl)pyrazol-1-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;7-[[4-[3-(1-methylpyrrolidin-3-yl)pyrazol-1-yl]phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-9-[[4-(3H-pyrrol-2-yl)phenyl]methyl]-7H-purin-8-one |
| SMILES | CC(C)c1ccccc1-c1ncc2[nH]c(=O)n(Cc3ccc(C4=NC=CC4)cc3)c2n1.CC(C)c1ccccc1-c1ncc2c(n1)N(Cc1ccc(-c3nc(C(F)(F)F)cn3C3CN(C)C3)cc1)C(=O)C2.CC(C)c1ccccc1-c1ncc2c(n1)N(Cc1ccc(-n3ccc(C4CCN(C)C4)n3)cc1)C(=O)C2.CC(C)c1ccccc1-c1ncc2c(n1)N(Cc1ccc(-n3ccc(C4CCN(C)CC4)n3)cc1)C(=O)C2.CC(C)c1ccccc1-c1ncc2c(n1)n(Cc1ccc(-c3nc(C(F)(F)F)cn3C3CNC3)cc1)c(=O)n2C |
| InChI | InChI=1S/C31H34N6O.C30H29F3N6O.C30H32N6O.C29H28F3N7O.C25H23N5O/c1-21(2)26-6-4-5-7-27(26)30-32-19-24-18-29(38)36(31(24)33-30)20-22-8-10-25(11-9-22)37-17-14-28(34-37)23-12-15-35(3)16-13-23;1-18(2)23-6-4-5-7-24(23)27-34-13-21-12-26(40)39(29(21)36-27)14-19-8-10-20(11-9-19)28-35-25(30(31,32)33)17-38(28)22-15-37(3)16-22;1-20(2)25-6-4-5-7-26(25)29-31-17-23-16-28(37)35(30(23)32-29)18-21-8-10-24(11-9-21)36-15-13-27(33-36)22-12-14-34(3)19-22;1-17(2)21-6-4-5-7-22(21)25-34-14-23-27(36-25)39(28(40)37(23)3)15-18-8-10-19(11-9-18)26-35-24(29(30,31)32)16-38(26)20-12-33-13-20;1-16(2)19-6-3-4-7-20(19)23-27-14-22-24(29-23)30(25(31)28-22)15-17-9-11-18(12-10-17)21-8-5-13-26-21/h4-11,14,17,19,21,23H,12-13,15-16,18,20H2,1-3H3;4-11,13,17-18,22H,12,14-16H2,1-3H3;4-11,13,15,17,20,22H,12,14,16,18-19H2,1-3H3;4-11,14,16-17,20,33H,12-13,15H2,1-3H3;3-7,9-14,16H,8,15H2,1-2H3,(H,28,31) |
| InChIKey | PYPFAWZEIMYCQB-UHFFFAOYSA-N |
| XLogP | 25.70 |
| TPSA | 359.94 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 29 |
| Heavy Atoms | 186 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2502.96 |
| LogP ≤ 5 | 25.70 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 31 |